ArticleJournal of hepatocellular carcinoma2025

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.

Xiaokun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.